{
    "clinical_study": {
        "@rank": "100896", 
        "biospec_descr": {
            "textblock": "Optical biopsy"
        }, 
        "biospec_retention": "None Retained", 
        "brief_summary": {
            "textblock": "Studies over the past two decades have convincingly demonstrated the role of barrier\n      dysfunction in the pathogenesis of inflammatory bowel disease. It previously shown that\n      optical biopsy with probe-based confocal laser endomicroscopy (pCLE) could be used to assess\n      mucosal barrier function. Furthermore, mucosal barrier dysfunction on pCLE was shown to be\n      predictive of disease relapse in adult IBD patients. The purpose of the current study is to\n      determine the predictive value of pCLE findings in pediatric IBD patients."
        }, 
        "brief_title": "Predictive Value of pCLE Findings in Pediatric IBD", 
        "completion_date": {
            "#text": "February 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Inflammatory Bowel Disease", 
        "condition_browse": {
            "mesh_term": [
                "Inflammatory Bowel Diseases", 
                "Intestinal Diseases"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  signed informed consent\n\n          -  patients with established IBD\n\n        Exclusion Criteria:\n\n          -  Any kind of allergy\n\n          -  Bronchial asthma\n\n          -  Liver or kidney disease\n\n          -  Inability to sign informed consent"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "21 Years", 
            "minimum_age": "10 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Pediatric patients with IBD from all over Russia, treated from IBD in our Center"
            }
        }, 
        "enrollment": {
            "#text": "26", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 30, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02003859", 
            "org_study_id": "SCCH-001"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "IBD", 
            "Pediatrics", 
            "pCLE"
        ], 
        "lastchanged_date": "December 5, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Moscow", 
                    "country": "Russian Federation", 
                    "zip": "119991"
                }, 
                "name": "The Scientific Center of Children's Health"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Russian Federation"
        }, 
        "number_of_groups": "1", 
        "official_title": "Predictive Value of pCLE Findings in Pediatric IBD", 
        "overall_contact": {
            "email": "shavrovnczd@yandex.ru", 
            "last_name": "Anton A Shavrov, M.D.", 
            "phone": "+7(916)4364099"
        }, 
        "overall_official": {
            "affiliation": "The Scientififc Center of Children's Health", 
            "last_name": "Andrey A Shavrov, M.D.", 
            "role": "Study Chair"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Russia: Ministry of Health of the Russian Federation", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The purpose of the current study is to determine the predictive value of pCLE findings in pediatric IBD patients.", 
            "measure": "Primary study end-point was moderate to severe flare requiring hospitalization after pCLE", 
            "safety_issue": "Yes", 
            "time_frame": "follow up period was a median of 18 months (range 4 to 33)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02003859"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Scientific Center of Children's Health RAMS", 
            "investigator_full_name": "Anton A. Shavrov", 
            "investigator_title": "M.D.", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Scientific Center of Children's Health RAMS", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "University of Alberta", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Harvard Medical School", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Scientific Center of Children's Health RAMS", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2010", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "December 2013"
    }
}